We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.51B
AUM Growth
-$307M
Cap. Flow
+$14.9M
Cap. Flow %
0.6%
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21

Top Buys

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$22.2M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$11.6M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$7.01M
4
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
+$6.39M
5
MATV icon
Mativ Holdings
MATV
+$5.91M

Top Sells

Rank Stock Value
1
MIME
Mimecast Limited
MIME
+$15.9M
2
ZGNX
Zogenix, Inc.
ZGNX
+$12.6M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$11.1M
4
NPTN
NEOPHOTONICS CORP
NPTN
+$6.5M
5
COLL icon
Collegium Pharmaceutical
COLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 23.72%
3 Industrials 14.58%
4 Consumer Discretionary 12.89%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
226
Berkshire Hathaway Class B
BRK.B
$1.13T
$1.56M 0.06%
4,434
-50
-1% -$16.2K
CODA icon
227
Coda Octopus Group
CODA
$117M
$1.54M 0.06%
234,515
+7,289
+3% +$48.2K
CNVY
228
DELISTED
Convey Health Solutions Holdings, Inc.
CNVY
$1.52M 0.06%
232,615
+2,700
+1% +$17.8K
OPRX icon
229
OptimizeRx
OPRX
$129M
$1.51M 0.06%
40,063
+1,063
+3% +$47K
PBYI icon
230
Puma Biotechnology
PBYI
$449M
$1.47M 0.06%
511,233
+19,951
+4% +$51.6K
SSTI icon
231
SoundThinking
SSTI
$105M
$1.42M 0.06%
51,248
+1,583
+3% +$43.1K
GBCI icon
232
Glacier Bancorp
GBCI
$6.35B
$1.35M 0.05%
+26,885
New +$1.45M
TDY icon
233
Teledyne Technologies
TDY
$32B
$1.21M 0.05%
2,556
-48
-2% -$20.6K
THS
234
DELISTED
Treehouse Foods
THS
$1.2M 0.05%
37,271
-455
-1% -$17.1K
CSTL icon
235
Castle Biosciences
CSTL
$988M
$1.17M 0.05%
26,151
+938
+4% +$38.8K
COLM icon
236
Columbia Sportswear
COLM
$2.92B
$1.16M 0.05%
12,808
-156
-1% -$14.4K
DENN
237
DELISTED
Denny's
DENN
$1.1M 0.04%
76,912
+2,485
+3% +$37.8K
ABBV icon
238
AbbVie
ABBV
$438B
$1.08M 0.04%
6,677
-300
-4% -$43.6K
YMAB
239
DELISTED
Y-mAbs Therapeutics
YMAB
$1.07M 0.04%
90,375
+5,980
+7% +$61.4K
AAPL icon
240
Apple
AAPL
$4.5T
$1.06M 0.04%
6,100
-1,468
-19% -$247K
NATI
241
DELISTED
National Instruments Corp
NATI
$1.04M 0.04%
25,537
-487
-2% -$19.7K
URGN icon
242
UroGen Pharma
URGN
$2.26B
$941K 0.04%
107,990
+6,631
+7% +$51.7K
ABT icon
243
Abbott
ABT
$188B
$821K 0.03%
6,936
-680
-9% -$84.3K
SMID icon
244
Smith-Midland
SMID
$146M
$715K 0.03%
40,264
+4,205
+12% +$106K
CVX icon
245
Chevron
CVX
$382B
$692K 0.03%
4,251
-392
-8% -$56.2K
HAS icon
246
Hasbro
HAS
$13.3B
$676K 0.03%
8,246
-235
-3% -$22K
LLY icon
247
Eli Lilly
LLY
$1.1T
$656K 0.03%
2,290
-100
-4% -$25.7K
MCO icon
248
Moody's
MCO
$82.8B
$644K 0.03%
1,910
-386
-17% -$130K
SRRK icon
249
Scholar Rock
SRRK
$6.32B
$599K 0.02%
46,508
+1,437
+3% +$24.6K
UPLD icon
250
Upland Software
UPLD
$14.5M
$571K 0.02%
3,243
+100
+3% +$18.3K
8 9
10
11 12

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Rice Hall James & Associates held 327 positions worth $2.51B, down 11% from $2.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q1 2022 filing shows 15 new, 111 increased, 164 reduced and 21 closed positions. Its largest new stake was Digital Turbine: 491,443 shares worth $21.5M. The largest sale was Mimecast Limited, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q1 2022 buy was Digital Turbine: 491,443 shares worth $21.5M.
  • Rice Hall James & Associates added most to Neurocrine Biosciences in Q1 2022, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2022 reduction was Mimecast Limited, cutting an estimated $15.9M.
  • Rice Hall James & Associates fully exited Zogenix, Inc. in Q1 2022, selling an estimated $12.6M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.51B portfolio in Q1 2022.
  • Rice Hall James & Associates opened 15 new positions and closed 21 in Q1 2022.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $2.51B.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.